Scarica l'app Stockscreener
1.17
0.85%
-0.01
Dopo l'orario di chiusura:
1.76
0.59
+50.43%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Biocardia Inc Borsa (BCDA) Ultime notizie
BioCardia submits FDA pre-submission for heart delivery catheter By Investing.com - Investing.com Nigeria
Biocardia files pre-submission for FDA approval of Helix(TM) - marketscreener.com
BioCardia (BCDA) Advances Helix Catheter Approval with FDA Pre-S - GuruFocus
BioCardia submits FDA pre-submission for heart delivery catheter - Investing.com
BioCardia Advances FDA Pathway for Helix Delivery Catheter - TipRanks
BioCardia Submits Pre-Submission to FDA for Helix Transendocardial Delivery Catheter Approval - Quiver Quantitative
BioCardia Files Pre-Submission for FDA Approval of Helix™ Transendocardial Delivery Catheter for Therapeutic and Diagnostic Agent Delivery to the Heart - marketscreener.com
Catheter to deliver cell and gene therapies to the heart heads to FDA - Stock Titan
Insider Buying: Peter Altman Acquires Additional Shares of BioCa - GuruFocus
BioCardia’s CardiAMP Heart Failure Data Selected for LBCT - TipRanks
BioCardia Announces Late Breaking Echocardiography Results from the CardiAMP HF Trial to be Presented at Technology and Heart Failure Therapeutics (THT) - The Manila Times
BioCardia, Inc. Announces Presentation of CardiAMP HF Trial Data - TradingView
Heart failure cell therapy trial lands late-breaking THT slot for echo data - stocktitan.net
Insider Sell: Will Matador Resources Company benefit from geopolitical trendsDividend Hike & Weekly Momentum Stock Picks - baoquankhu1.vn
Activity Recap: Does BioCardia Inc have consistent dividend growthQuarterly Trade Review & Growth Oriented Trade Recommendations - baoquankhu1.vn
Aug Ideas: Whats Sono Tek Corporations historical returnPortfolio Value Report & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
Chipmakers Recap: Should you avoid BioCardia Inc stock right now2025 Earnings Impact & Safe Swing Trade Setup Alerts - baoquankhu1.vn
IO Biotech (IOBT) Explores Strategic Alternatives, Stock Surges 19.36% - Intellectia AI
Altman Peter buys BioCardia (BCDA) shares worth $1,194 By Investing.com - Investing.com Nigeria
Altman Peter buys BioCardia (BCDA) shares worth $1,194 - Investing.com
Trend Review: Is BioCardia Inc. in a long term uptrendWeekly Investment Summary & Weekly Top Gainers Alerts - baoquankhu1.vn
US Stocks Recap: Can BioCardia Inc expand its profit marginsJuly 2025 Big Picture & Weekly Chart Analysis and Guides - baoquankhu1.vn
Swing Trade: Is BioCardia Inc stock forming a triangle patternGap Up & High Accuracy Trade Alerts - baoquankhu1.vn
Can BioCardia Inc. stock deliver surprise earnings beat2025 Buyback Activity & AI Enhanced Trade Execution Alerts - Bộ Nội Vụ
Published on: 2026-01-10 18:46:33 - Улправда
Will BioCardia Inc. (6JU0) stock keep high P E multiplesPortfolio Return Report & Reliable Entry Point Alerts - Улправда
Can BioCardia Inc. stock continue upward trendWeekly Stock Report & AI Optimized Trading Strategy Guides - Улправда
Forecast Cut: Will BioCardia Inc. stock rally after Fed decisionsJuly 2025 Weekly Recap & Daily Entry Point Alerts - ulpravda.ru
Will BioCardia Inc. stock rally after Fed decisionsMarket Activity Report & Community Trade Idea Sharing Platform - Улправда
How BioCardia Inc. stock reacts to bond yields2026 world cup usa national team qualification midfield engines set piece tactics expert forecast analysis - Улправда
Bull Run: Why analysts raise outlook for BioCardia Inc 6JU0 stock2025 Market Outlook & Daily Profit Focused Stock Screening - moha.gov.vn
Profit Review: Will BioCardia Inc 6JU0 stock sustain uptrend momentumJuly 2025 Volume & Safe Capital Growth Stock Tips - moha.gov.vn
Is BioCardia Inc 6JU0 a good long term investmentEconomic Indicators Overview & Free Stay Ahead With Picks - earlytimes.in
BioCardia (BCDA) Stock Analysis Report | Financials & Insights - Benzinga
BioCardia advances CardiAMP therapy in Japan - MSN
Will BioCardia Inc. stock deliver long term returns2025 Technical Patterns & Daily Growth Stock Tips - Улправда
Will BioCardia Inc. stock keep outperforming rivals2025 Winners & Losers & Weekly Top Performers Watchlists - Улправда
Why BioCardia Inc. stock remains on buy lists2025 Winners & Losers & Consistent Income Trade Ideas - Улправда
Is BioCardia Inc. (6JU0) stock prepared for digital transitionTake Profit & Fast Exit Strategy with Risk Control - Улправда
Why retail investors pile into BioCardia Inc. stock2025 Volume Leaders & Reliable Volume Spike Trade Alerts - Улправда
Why BioCardia Inc. (6JU0) stock is trending on social media2025 Technical Patterns & Technical Entry and Exit Tips - Улправда
Is BioCardia Inc. (6JU0) stock protected from inflationJuly 2025 Earnings & Precise Swing Trade Alerts - Улправда
Is BioCardia Inc. stock attractive for ETFsMarket Performance Recap & Daily Price Action Insights - Улправда
BioCardia (BCDA) registers 424,509 incentive plan shares after 2025 vote - Stock Titan
Meme Stocks: Will BioCardia Inc. stock deliver long term returnsJuly 2025 EndofMonth & Verified Entry Point Signals - Улправда
BioCardia first patient enrolled at Henry Ford Health for Phase 3 CardiAMP - MSN
CEO Altman Buys 1,100 ($1.4K) Of BioCardia Inc [BCDA] - TradingView — Track All Markets
BioCardia (BCDA) CEO and president discloses December insider share buys - Stock Titan
BioCardia (BCDA) Advances CardiAMP Therapy for Heart Failure in Japan - GuruFocus
Biocardia cell therapy to enter PMDA clinical consultation - marketscreener.com
BioCardia Advances CardiAMP Therapy in Japan - TipRanks
BioCardia Cell Therapy for Ischemic Heart Failure to Progress to Formal Clinical Consultation with Japan PMDA - The Manila Times
BioCardia Advances CardiAMP Cell Therapy for Heart Failure with PMDA Consultation Completion - Quiver Quantitative
BioCardia, Inc Advances CardiAMP Cell Therapy in Japan - TradingView — Track All Markets
BioCardia (NASDAQ: BCDA) moves to PMDA consultation on heart failure therapy - Stock Titan
BioCardia (NASDAQ: BCDA) allowed to advance to formal PMDA consultation on CardiAMP HFrEF - Stock Titan
BioCardia appoints Slosman to its Board of Directors - MSN
1.24%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):